Assistant Investigator, Neurology, Mass General Research Institute and Assistant Professor of Neurology, Harvard Medical School

Dr. Jackson's research focuses on midlife and late-life health disparities in clinical settings that affect Black populations. Dr. Jackson also works as a cognitive neuroscientist, investigating the early detection of Alzheimer's disease (AD), particularly in the absence of overt memory problems. He serves on Massachusetts General Hospital's Alzheimer's Disease Research Center (ADRC) and Mass General's Cancer Center Equity Program, specializing in identifying and overcoming barriers to clinical research for people and communities of color.

Professor of Medicine, Division of Geriatric Medicine, Senior Vice President and Senior Associate Dean, for Health Equity and Inclusive Excellence, Vanderbilt University

Among Dr. Wilkins’ many contributions to science is her prescient focus on engaging racial and ethnic minority communities, using implementation science methodologies in the design and conduct of clinical research. She has pioneered efforts to move the academic and clinical research enterprise to transform approaches to clinical research design by embedding participant and community engagement in every aspect of biomedical discovery. An elected member of the National Academy of Medicine, she has published over 100 papers on her research.

Association Professor of Geriatrics and Gerontology, University of Wisconsin–Madison, and Leader, Inclusion of Under-Represented Groups Core, Wisconsin Alzheimer’s Disease Research Center

Dr. Gleason’s research aims to improve timely identification of and intervention for memory disorders in underserved communities. She is the principal or co-investigator on numerous research projects examining modifiable risk factors, including cardiovascular disease, emotional health, and social context.

Instructor in Neurology and Leader, Knight ADRC Outreach, Recruitment, and Engagement Core Leader, Washington University School of Medicine

The focus of Andrea Denny's research and practice is Alzheimer's disease and related diseases (ADRD) associated with aging. Specific interests include improving recruitment and retention of research volunteers in ADRD research. She also has an interest in the dissemination of knowledge from the academic setting to the community including historically minoritized and rural communities, Her work centers on ways to improve outcomes for those living with ADRD and their care partners.

Associate Professor of Neurology, Leader, Health Disparities and Equity Core, Knight ADRC, Washington University School of Medicine

Joyce (Joy) E. Balls-Berry, Ph.D., is a psychiatric epidemiologist and health educator. Her primary research focuses on applying community and patient engaged research principles in diverse populations to reduce health disparities and increase health equity. Much of Dr. Balls-Berry’s research centers on determining ways to increase diversity and inclusion in clinical and translational science.

Professor, Community Health Systems, School of Nursing, University of California, San Francisco

Dr. Park's primary research interest is to address issues related to racial and ethnic minority health and healthcare disparities, especially among Asian Americans and Pacific Islanders (AAPI), through community-based participatory research. Her research areas include mental health and Alzheimer's disease and related dementias (ADRD) caregiving.

Ballantine Chair in Geriatrics and Director, Alzheimer Disease Research Center, University Wisconsin

Dr. Asthana’s research program broadly focuses on clinical psychopharmacology and neuroendocrinology of gonadal steroids and cholinergic drugs in Alzheimer’s disease and healthy aging.

Associate Professor, Department of Medicine and the Wisconsin Alzheimer Disease Research Center, University Wisconsin – Madison

Dr. Okonkwo's research focuses on clarifying how alterations in the brain and other biomolecules (such as cerebrospinal fluid β-amyloid) place some cognitively-normal individuals on a trajectory that culminates in probable Alzheimer’s disease. He is also interested in discovering new knowledge concerning the modulation of the link between brain changes and cognitive decline by both modifiable (e.g., cognitively-stimulating activities, physical exercise) and non-modifiable (e.g., genetic vulnerability) factors.

Project Manager, Trusting Research, University of California, San Francisco

Tamara’s personal mission is to make a positive impact on human health. With a background in biomedical science and business administration, Tamara has contributed to various organizations in the Academic Research, Healthcare and Biotech industries over the past ten years by crafting strategy, as well as leading the operation and implementation efforts. Tamara has a keen interest in the following areas; Health policy, Change management, and Empowerment of underrepresented communities.